# RareDXAI: Final Scientific Quality & Deliverable Audit

**Project:** *RareDXAI: A Human Phenotype Ontology-Based Framework for Rare Disease Prediction*  
**Date:** September 6, 2026  
**Audited Status:** 100% VERIFIED & LOCKED  

---

## 1. 24-Point Quality Verification Matrix

| # | Verification Criterion | Authoritative Repository Standard | Verified Implementation | Status |
| :-: | :--- | :--- | :--- | :---: |
| **1** | **Exact Section Sequence** | Abstract $\rightarrow$ Intro $\rightarrow$ Lit Survey $\rightarrow$ Math $\rightarrow$ Methods $\rightarrow$ Results $\rightarrow$ Conclusion $\rightarrow$ References | Followed exactly; no detached discussion/limitations sections | **PASSED** |
| **2** | **Accessible Academic Writing** | Clear, simple English; technical terms explained on first occurrence | HPO, ML, RF, SHAP, calibration, splits, and OCR explained simply | **PASSED** |
| **3** | **Cohort Total** | Total verified patients $N = 385$ | $N = 385$ (KBG: $298$, WS: $45$, XG: $42$) | **PASSED** |
| **4** | **Cohort Proportions** | KBG: 77.40%, White-Sutton: 11.69%, Xia-Gibbs: 10.91% | Verified in Table 3, Figure 4, and text | **PASSED** |
| **5** | **Demographics (Sex)** | Male: 203 (52.7%), Female: 165 (42.9%), Unknown: 17 (4.4%) | Verified in Table 3 and dataset audit | **PASSED** |
| **6** | **Contributing Publications** | Exactly 48 peer-reviewed publications | Verified in Table 2, Figure 3, and provenance manifest | **PASSED** |
| **7** | **Literature Evaluated** | 52 literature sources evaluated during curation | Verified in Table 2, Figure 3, and text | **PASSED** |
| **8** | **Quarantined Records** | 4 sources (59 duplicate candidate records) quarantined | Verified in Table 2, Figure 3, and text | **PASSED** |
| **9** | **HPO Feature Space** | 82 cohort terms, 78 training terms, 3 sex features = 81 ML dims | Verified in Methods and model matrices | **PASSED** |
| **10**| **Data Splits** | 60/20/20 profile-grouped split (Train: 230, Val: 77, Test: 78) | Verified in Methods and split logs | **PASSED** |
| **11**| **Held-Out Test Accuracy** | 98.72% (77/78 correct, Wilson 95% CI: 93.09%–99.77%) | Verified in Table 4, Figure 6, and text | **PASSED** |
| **12**| **Held-Out Test Metrics** | Bal Acc: 96.30%, Prec: 99.45%, Rec: 96.30%, Spec: 98.15%, F1: 97.76% | Verified in Table 4, Table 5, Figure 6 | **PASSED** |
| **13**| **Per-Class Metrics** | WS F1: 0.9412 (8/9), XG F1: 1.0000 (9/9), KBG F1: 0.9917 (60/60) | Verified in Table 5 and confusion matrix | **PASSED** |
| **14**| **Probability Calibration** | Multiclass Brier: 0.0419, Mean OvR Brier: 0.0140, ECE: 8.59% | Verified in Table 4, Table 5, Figure 9 | **PASSED** |
| **15**| **Threshold Discrimination** | Macro AUROC = 1.0000, Macro AUPRC = 1.0000 | Verified in Table 4, Table 5, Figure 10 | **PASSED** |
| **16**| **Cross-Validation** | 5-Fold Stratified Grouped CV: Acc = 97.14% ± 2.23%, F1 = 94.89% ± 4.04% | Verified in Results and Figure 7 | **PASSED** |
| **17**| **Stress Validation** | Source-Grouped CV: Acc = 79.62% ± 27.05%, F1 = 59.51% ± 26.81% | Documented transparently in Results and Figure 7 | **PASSED** |
| **18**| **SHAP Terminology** | Cautious non-causal phrasing ("strongly associated with boundaries") | Verified in Table 6, Figure 8, and text | **PASSED** |
| **19**| **OCR Evaluation** | CER = 11.42%, WER = 92.00%, Clean = 100%, Noisy = 80% | Designated as exploratory upstream utility | **PASSED** |
| **20**| **Claim Safety Compliance**| Zero forbidden terms ("100% accurate", "clinically validated", "zero leakage") | Full compliance with claim safety audit guide | **PASSED** |
| **21**| **Literature References** | Exactly 15 peer-reviewed citations from 2020–2026 | Verified real papers with DOIs and comparison matrix | **PASSED** |
| **22**| **Real Figures & Tables** | All tables editable; all 10 figures embedded at 300 DPI | All assets generated from repository data | **PASSED** |
| **23**| **Editable Word Document** | `reports/RareDXAI_Research_Manuscript_FINAL.docx` | Generated with python-docx, styled headings/tables | **PASSED** |
| **24**| **Complete Markdown & PDF**| `FINAL.md` and `FINAL.pdf` generated and verified | Generated and validated | **PASSED** |

---

## 2. Generated Artifacts Inventory

- [`reports/RareDXAI_Research_Manuscript_FINAL.docx`](file:///d:/finalresearchproject/reports/RareDXAI_Research_Manuscript_FINAL.docx) — Primary editable Microsoft Word manuscript
- [`reports/RareDXAI_Research_Manuscript_FINAL.md`](file:///d:/finalresearchproject/reports/RareDXAI_Research_Manuscript_FINAL.md) — Complete Markdown manuscript
- [`reports/RareDXAI_Research_Manuscript_FINAL.pdf`](file:///d:/finalresearchproject/reports/RareDXAI_Research_Manuscript_FINAL.pdf) — Publication PDF document
- [`reports/RareDXAI_Final_Quality_Check.md`](file:///d:/finalresearchproject/reports/RareDXAI_Final_Quality_Check.md) — This audit verification report
